Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4231)
All Articles published online
|
Dec 7, 2006 (publication date) through Dec 11, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lodato F, Mazzella G, Festi D, Azzaroli F, Colecchia A, Roda E. Hepatocellular carcinoma prevention: A worldwide emergence between the opulence of developed countries and the economic constraints of developing nations. World J Gastroenterol 2006; 12(45): 7239-7249 [PMID: 17143937 DOI: 10.3748/wjg.v12.i45.7239] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i45/7239.htm |
| Number | Citing Articles |
| 1 |
Mary Qian YY, Rong Yuwei J, Peter Angus, Tony Schelleman, Lynne Johnson, Paul Gow. Efficacy and cost of a hepatocellular carcinoma screening program at an Australian teaching hospital. Journal of Gastroenterology and Hepatology 2010; 25(5): 951 doi: 10.1111/j.1440-1746.2009.06203.x
|
| 2 |
Melanie B. Thomas, Marta Davila, James L. Abbruzzese. Stemming the Tide of Hepatitis B Virus–Related Hepatocellular Carcinoma?. Journal of Clinical Oncology 2008; 26(2): 172 doi: 10.1200/JCO.2007.14.4337
|
| 3 |
Wonhee Hur, Hyangshuk Rhim, Chan Kwon Jung, Jin Dong Kim, Si Hyun Bae, Jeong Won Jang, Jin Mo Yang, Seong-Taek Oh, Dong Goo Kim, Hee Jung Wang, Sean Bong Lee, Seung Kew Yoon. SOX4 overexpression regulates the p53-mediated apoptosis in hepatocellular carcinoma: clinical implication and functional analysis in vitro. Carcinogenesis 2010; 31(7): 1298 doi: 10.1093/carcin/bgq072
|
| 4 |
Wei Cheng, Po-Chun Huang, Hsiao-Mei Chao, Yung-Ming Jeng, Hey-Chi Hsu, Hung-Wei Pan, Wuh-Liang Hwu, Yu-May Lee. Glypican-3 induces oncogenicity by preventing IGF-1R degradation, a process that can be blocked by Grb10. Oncotarget 2017; 8(46): 80429 doi: 10.18632/oncotarget.19035
|
| 5 |
Alan P. Venook, Christos Papandreou, Junji Furuse, Laura Ladrón de Guevara. The Incidence and Epidemiology of Hepatocellular Carcinoma: A Global and Regional Perspective. The Oncologist 2010; 15(S4): 5 doi: 10.1634/theoncologist.2010-S4-05
|
| 6 |
Kasper J. Andersen, Henning Grønbæk, Gerda Elisabeth Villadsen, Anders Riegels Knudsen, Peter Ott, Hendrik Vildstrup, Dennis Tønner Nielsen, Arindam Bharadwaz. Chemoembolization of intermediate stage hepatocellular carcinomas: Results from a Nordic tertiary liver cancer center. Indian Journal of Gastroenterology 2014; 33(4): 322 doi: 10.1007/s12664-013-0428-9
|
| 7 |
Yong Chun Chong, Tau En Lim, Yanyun Fu, Eun Myoung Shin, Vinay Tergaonkar, Weiping Han. Indian Hedgehog links obesity to development of hepatocellular carcinoma. Oncogene 2019; 38(12): 2206 doi: 10.1038/s41388-018-0585-5
|
| 8 |
Adrian Reuben. Alcohol and the liver. Current Opinion in Gastroenterology 2007; 23(3): 283 doi: 10.1097/MOG.0b013e3280f27582
|
| 9 |
Regina Zi Hwei Tan, Ian Lockart, Christina Abdel Shaheed, Mark Danta. Systematic review with meta‐analysis: The effects of non‐steroidal anti‐inflammatory drugs and anti‐platelet therapy on the incidence and recurrence of hepatocellular carcinoma. Alimentary Pharmacology & Therapeutics 2021; 54(4): 356 doi: 10.1111/apt.16515
|
| 10 |
Süleyman Bayram, Hikmet Akkız, Aynur Bekar, Ersin Akgöllü, Selçuk Yıldırım. The significance of Exonuclease 1 K589E polymorphism on hepatocellular carcinoma susceptibility in the Turkish population: a case–control study. Molecular Biology Reports 2012; 39(5): 5943 doi: 10.1007/s11033-011-1406-x
|
| 11 |
Guo Long, Tongdi Fang, Wenxin Su, Xingyu Mi, LeDu Zhou. The prognostic value of postoperative circulating cell-free DNA in operable hepatocellular carcinoma. Scandinavian Journal of Gastroenterology 2020; 55(12): 1441 doi: 10.1080/00365521.2020.1839127
|
| 12 |
Paolo Sorrentino, Salvatore D’Angelo, Umberto Ferbo, Pietro Micheli, Alessandra Bracigliano, Raffaela Vecchione. Liver iron excess in patients with hepatocellular carcinoma developed on non-alcoholic steato-hepatitis. Journal of Hepatology 2009; 50(2): 351 doi: 10.1016/j.jhep.2008.09.011
|
| 13 |
Hyun Young Woo, Jeong Heo. Sorafenib in liver cancer. Expert Opinion on Pharmacotherapy 2012; 13(7): 1059 doi: 10.1517/14656566.2012.679930
|
| 14 |
Myeong Jun Song, Chan Kwon Jung, Chung‐Hwa Park, Wonhee Hur, Jung Eun Choi, Si Hyun Bae, Jong Young Choi, Sang Wook Choi, Nam Ik Han, Seung Kew Yoon. RPL36 as a prognostic marker in hepatocellular carcinoma. Pathology International 2011; 61(11): 638 doi: 10.1111/j.1440-1827.2011.02716.x
|
| 15 |
Xin Wang, Yangchao Chen, Quan‐bin Han, Chu‐yan Chan, Hua Wang, Zheng Liu, Christopher Hon‐ki Cheng, David T. Yew, Marie C.M. Lin, Ming‐liang He, Hong‐xi Xu, Joseph J.Y. Sung, Hsiang‐fu Kung. Proteomic identification of molecular targets of gambogic acid: Role of stathmin in hepatocellular carcinoma. PROTEOMICS 2009; 9(2): 242 doi: 10.1002/pmic.200800155
|
| 16 |
Jian‐Gao Fan, Geoffrey C Farrell. Prevention of hepatocellular carcinoma in nonviral‐related liver diseases. Journal of Gastroenterology and Hepatology 2009; 24(5): 712 doi: 10.1111/j.1440-1746.2009.05776.x
|
| 17 |
Roman Kloeckner, Gerd Otto, Stefan Biesterfeld, Katja Oberholzer, Christoph Dueber, Michael B. Pitton. MDCT Versus MRI Assessment of Tumor Response After Transarterial Chemoembolization for the Treatment of Hepatocellular Carcinoma. CardioVascular and Interventional Radiology 2010; 33(3): 532 doi: 10.1007/s00270-009-9728-y
|
| 18 |
Yun-Chih Hsieh, Yerra Koteswara Rao, Chun-Chi Wu, Chi-Ying F. Huang, Madamanchi Geethangili, Shih-Lan Hsu, Yew-Min Tzeng. Methyl Antcinate A from Antrodia camphorata Induces Apoptosis in Human Liver Cancer Cells through Oxidant-Mediated Cofilin- and Bax-Triggered Mitochondrial Pathway. Chemical Research in Toxicology 2010; 23(7): 1256 doi: 10.1021/tx100116a
|
| 19 |
Arjun Kumar Kalimuthu, Pavadai Parasuraman, Pandian Sivakumar, Sankaranarayanan Murugesan, Sankarganesh Arunachalam, Sureshbabu Ram Kumar Pandian, Vigneshwaran Ravishankar, Damodar Nayak Ammunje, Muthukumar Sampath, Theivendran Panneerselvam, Selvaraj Kunjiappan. In silico, in vitro screening of antioxidant and anticancer potentials of bioactive secondary metabolites from an endophytic fungus (Curvularia sp.) from Phyllanthus niruri L. Environmental Science and Pollution Research 2022; 29(32): 48908 doi: 10.1007/s11356-022-19249-0
|
| 20 |
Michael Bernhard Pitton, Roman Kloeckner, Sascha Herber, Gerd Otto, Karl Friedrich Kreitner, Christoph Dueber. MRI <italic>versus</italic> 64-row MDCT for diagnosis of hepatocellular carcinoma. World Journal of Gastroenterology 2009; 15(48): 6044-6051 doi: 10.3748/wjg.15.6044
|
| 21 |
Yanting Qi, Xiaona Chen, Chu‐yan Chan, Dan Li, Chonggang Yuan, Fei Yu, Marie C. Lin, David T. Yew, Hsiang‐Fu Kung, Lihui Lai. Two‐dimensional differential gel electrophoresis/analysis of diethylnitrosamine induced rat hepatocellular carcinoma. International Journal of Cancer 2008; 122(12): 2682 doi: 10.1002/ijc.23464
|
| 22 |
Yun Lu, Bing-Yuan Zhang, Bao-Lei Wang, Xi-Bao Sun, Qian Dong. The Effects of Stichopus japonicus Acid Mucopolysaccharide on the Apoptosis of the Human Hepatocellular Carcinoma Cell Line HepG2. The American Journal of the Medical Sciences 2010; 339(2): 141 doi: 10.1097/MAJ.0b013e3181c20d01
|
| 23 |
Pierre Nahon, Angela Sutton, Pierre Rufat, Marianne Ziol, Gabriel Thabut, Pierre–Olivier Schischmanoff, Dominique Vidaud, Nathalie Charnaux, Philippe Couvert, Nathalie Ganne–Carrie, Jean–Claude Trinchet, Liliane Gattegno, Michel Beaugrand. Liver Iron, HFE Gene Mutations, and Hepatocellular Carcinoma Occurrence in Patients With Cirrhosis. Gastroenterology 2008; 134(1): 102 doi: 10.1053/j.gastro.2007.10.038
|
| 24 |
LING LIU, JINGKAI ZHANG, MEILING LI, XIAOHONG ZHANG, JINLU ZHANG, ZHENJING LI, LIKUI WANG, JIHUI WU, CHENG LUO. Inhibition of HepG2 cell proliferation by ursolic acid and polysaccharides via the downregulation of cyclooxygenase-2. Molecular Medicine Reports 2014; 9(6): 2505 doi: 10.3892/mmr.2014.2059
|
| 25 |
J.S. Lubel, F.J. Warner, P.W. Angus. Frontiers in Research of the Renin-Angiotensin System on Human Disease. 2007; : 113 doi: 10.1007/978-1-4020-6372-5_6
|
| 26 |
Delong Liu, Wanbin Zhang. Pharmaceutical Process Chemistry. 2010; : 273 doi: 10.1002/9783527633678.ch14
|
| 27 |
John FP Bridges, Gisselle Gallego, Barri M Blauvelt. Controlling liver cancer internationally: A qualitative study of clinicians' perceptions of current public policy needs. Health Research Policy and Systems 2011; 9(1) doi: 10.1186/1478-4505-9-32
|
| 28 |
Vairappan Balasubramaniyan, Ruchi Shukla, Gopal Murugaiyan, Ramchandra Ramesh Bhonde, Namasivayam Nalini. Mouse recombinant leptin protects human hepatoma HepG2 against apoptosis, TNF-α response and oxidative stress induced by the hepatotoxin–ethanol. Biochimica et Biophysica Acta (BBA) - General Subjects 2007; 1770(8): 1136 doi: 10.1016/j.bbagen.2007.04.009
|
| 29 |
A. Sawadogo, T. M. Yaméogo, C. G. Kyelem, Z. Nikiema, W. Bassolé, S. M. Ouédraogo, M. M. Rouamba, A. Millogo. Caractéristiques des ictères à bilirubine conjuguée chez l’adulte dans un CHU au Burkina Faso. Journal Africain d'Hépato-Gastroentérologie 2013; 7(1): 27 doi: 10.1007/s12157-012-0433-4
|
| 30 |
Süleyman Bayram, Hikmet Akkız, Mehmet Topaktaş. CHK2 1100delC, IVS2+1G>A and I157T mutations are not present in hepatocellular cancer cases from a Turkish population. Gene 2013; 512(2): 232 doi: 10.1016/j.gene.2012.10.045
|
| 31 |
Jing‐hui Tian, Wen‐dong Liu, Zhi‐yong Zhang, Li‐hua Tang, Dong Li, Zhao‐ju Tian, Shao‐wei Lin, Ying‐jie Li. Influence of miR‐520e‐mediated MAPK signalling pathway on HBV replication and regulation of hepatocellular carcinoma cells via targeting EphA2. Journal of Viral Hepatitis 2019; 26(4): 496 doi: 10.1111/jvh.13048
|
| 32 |
Wei Cheng, Chia-Jen Tseng, Tom T.C. Lin, I. Cheng, Hung-Wei Pan, Hey-Chi Hsu, Yu-May Lee. Glypican-3-mediated oncogenesis involves the Insulin-like growth factor-signaling pathway. Carcinogenesis 2008; 29(7): 1319 doi: 10.1093/carcin/bgn091
|
| 33 |
Amal F. Gharib, Rehab A. Karam, Heba F. Pasha, Mohamed I. Radwan, Wael H. Elsawy. Polymorphisms of hemochromatosis, and alpha-1 antitrypsin genes in Egyptian HCV patients with and without hepatocellular carcinoma. Gene 2011; 489(2): 98 doi: 10.1016/j.gene.2011.08.010
|
| 34 |
Amanda do Rocio Andrade Pires, Andrea Caroline Ruthes, Silvia Maria Suter Correia Cadena, Marcello Iacomini. Cytotoxic effect of a mannogalactoglucan extracted from Agaricus bisporus on HepG2 cells. Carbohydrate Polymers 2017; 170: 33 doi: 10.1016/j.carbpol.2017.04.050
|
| 35 |
Debojyoti Halder, Ashutosh Gupta, Subhasis Chakraborty, Partha Roy, Kalyan Kumar Sen. Upgraded theragnostic strategies of multivariate nano gold in the management of hepatocellular carcinoma. Nano-Structures & Nano-Objects 2024; 40: 101342 doi: 10.1016/j.nanoso.2024.101342
|
| 36 |
Tomonori Iida, Hiroaki Shiba, Takeyuki Misawa, Toya Ohashi, Yoshikatsu Eto, Katsuhiko Yanaga. Adenovirus-mediated CD40L gene therapy induced both humoral and cellular immunity against rat model of hepatocellular carcinoma. Cancer Science 2008; doi: 10.1111/j.1349-7006.2007.00953.x
|
| 37 |
Junting Huang, Yaojun Zhang, Zhenwei Peng, Hengjun Gao, Li Xu, Long R. Jiao, Minshan Chen. A modified TNM-7 staging system to better predict the survival in patients with hepatocellular carcinoma after hepatectomy. Journal of Cancer Research and Clinical Oncology 2013; 139(10): 1709 doi: 10.1007/s00432-013-1497-y
|
| 38 |
Ichiro Yamato, Tadatoshi Takayama, Yutaka Midorikawa, Tokio Higaki, Hisashi Nakayama, Masamichi Moriguchi, Yoshiyuki Nakajima, Shunichi Matsuoka, Masahiro Ogawa, Mitsuhiko Moriyama. Postoperative outcomes of patients with hepatocellular carcinoma negative for all virus-related markers. Surgery Today 2013; 43(8): 865 doi: 10.1007/s00595-012-0308-4
|
| 39 |
Yanjing Chen, Yuan Chen, Da Xiao, Arijit Bose, Ruitang Deng, Geoffrey D. Bothun. Low-dose chemotherapy of hepatocellular carcinoma through triggered-release from bilayer-decorated magnetoliposomes. Colloids and Surfaces B: Biointerfaces 2014; 116: 452 doi: 10.1016/j.colsurfb.2014.01.022
|
| 40 |
Chun-Chieh Yeh, Pei-Ying Liao, Sudhir Pandey, Su-Yung Yung, Hsueh-Chou Lai, Long-Bin Jeng, Wei-Chun Chang, Wen-Lung Ma. Metronomic Celecoxib Therapy in Clinically Available Dosage Ablates Hepatocellular Carcinoma via Suppressing Cell Invasion, Growth, and Stemness in Pre-Clinical Models. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.572861
|
| 41 |
M Dai, J Liu, D-E Chen, Y Rao, Z-J Tang, W-Z Ho, C-Y Dong. Tumor-targeted gene therapy using Adv-AFP-HRPC/IAA prodrug system suppresses growth of hepatoma xenografted in mice. Cancer Gene Therapy 2012; 19(2): 77 doi: 10.1038/cgt.2011.65
|
| 42 |
S Sultana, S Nafees, AQ Khan. Perillyl alcohol as a protective modulator against rat hepatocarcinogenesis via amelioration of oxidative damage and cell proliferation. Human & Experimental Toxicology 2013; 32(11): 1179 doi: 10.1177/0960327112474834
|
| 43 |
Seunghee Han, Joon-Il Choi, Michael Yong Park, Moon Hyung Choi, Sung Eun Rha, Young Joon Lee. The Diagnostic Performance of Liver MRI without Intravenous Contrast for Detecting Hepatocellular Carcinoma: A Case-Controlled Feasibility Study. Korean Journal of Radiology 2018; 19(4): 568 doi: 10.3348/kjr.2018.19.4.568
|
| 44 |
Han Ki Lee, Heui Min Lim, See-Hyoung Park, Myeong Jin Nam. Knockout of Hepatocyte Growth Factor by CRISPR/Cas9 System Induces Apoptosis in Hepatocellular Carcinoma Cells. Journal of Personalized Medicine 2021; 11(10): 983 doi: 10.3390/jpm11100983
|
| 45 |
Süleyman Bayram. RASSF1A Ala133Ser polymorphism is associated with increased susceptibility to hepatocellular carcinoma in a Turkish population. Gene 2012; 498(2): 264 doi: 10.1016/j.gene.2012.02.040
|
| 46 |
Italo Bonadio, Isabelle Colle, Anja Geerts, Peter Smeets, Giammauro Berardi, Marleen Praet, Xavier Rogiers, Bernard de Hemptinne, Hans Van Vlierberghe, Roberto I. Troisi. Liver transplantation for hepatocellular carcinoma comparing the Milan, UCSF, and Asan criteria: long‐term follow‐up of a Western single institutional experience. Clinical Transplantation 2015; 29(5): 425 doi: 10.1111/ctr.12534
|
| 47 |
Likui Wang, Shijuan Gao, Wei Jiang, Cheng Luo, Maonian Xu, Lars Bohlin, Markus Rosendahl, Wenlin Huang. Antioxidative Dietary Compounds Modulate Gene Expression Associated with Apoptosis, DNA Repair, Inhibition of Cell Proliferation and Migration. International Journal of Molecular Sciences 2014; 15(9): 16226 doi: 10.3390/ijms150916226
|
| 48 |
J. F. P. Bridges, S. M. Joy, B. M. Blauvelt, W. Yan, J. A. Marsteller. An international comparison of stakeholder motivation to implement liver cancer control. Health Policy and Planning 2015; 30(5): 645 doi: 10.1093/heapol/czu044
|
| 49 |
Tomonori Iida, Hiroaki Shiba, Takeyuki Misawa, Toya Ohashi, Yoshikatsu Eto, Katsuhiko Yanaga. Adenovirus‐mediated CD40L gene therapy induced both humoral and cellular immunity against rat model of hepatocellular carcinoma. Cancer Science 2008; 99(10): 2097 doi: 10.1111/j.1349-7006.2008.00953.x
|
| 50 |
Ke‐qi Han, Hui Han, Xue‐qun He, Lei Wang, Xiao‐dong Guo, Xue‐ming Zhang, Jie Chen, Quan‐gang Zhu, Hua Nian, Xiao‐feng Zhai, Ma‐wei Jiang. Chemokine CXCL1 may serve as a potential molecular target for hepatocellular carcinoma. Cancer Medicine 2016; 5(10): 2861 doi: 10.1002/cam4.843
|
| 51 |
Selin Oncul, Gulsah Karakaya, Mutlu Dilsiz Aytemir, Ayse Ercan. A kojic acid derivative promotes intrinsic apoptotic pathway of hepatocellular carcinoma cells without incurring drug resistance. Chemical Biology & Drug Design 2019; 94(6): 2084 doi: 10.1111/cbdd.13615
|
| 52 |
Juan Jose Urquijo-Ponce, Carlos Alventosa-Mateu, Mercedes Latorre-Sánchez, Inmaculada Castelló-Miralles, Moisés Diago. Present and future of new systemic therapies for early and intermediate stages of hepatocellular carcinoma. World Journal of Gastroenterology 2024; 30(19): 2512-2522 doi: 10.3748/wjg.v30.i19.2512
|
| 53 |
Jia Huang, Yaojun Zhang, Meixian Chen, Junting Huang, Li Xu, Minshan Chen. Family history of hepatocellulcar carcinoma is not associated with its patients’ prognosis after hepatectomy. World Journal of Surgical Oncology 2013; 11(1) doi: 10.1186/1477-7819-11-280
|
| 54 |
SUSANNE GAHR, CHRISTIAN MAYR, TOBIAS KIESSLICH, ROMANA ILLIG, DANIEL NEUREITER, BEATE ALINGER, MARION GANSLMAYER, TILL WISSNIOWSKI, PIETRO DI FAZIO, ROBERTA MONTALBANO, JOACHIM H. FICKER, MATTHIAS OCKER, KARL QUINT. The pan-deacetylase inhibitor panobinostat affects angiogenesis in hepatocellular carcinoma models via modulation of CTGF expression. International Journal of Oncology 2015; 47(3): 963 doi: 10.3892/ijo.2015.3087
|
| 55 |
Akane Ui, Shinichi Kuriyama, Masako Kakizaki, Toshimasa Sone, Naoki Nakaya, Kaori Ohmori-Matsuda, Atsushi Hozawa, Yoshikazu Nishino, Ichiro Tsuji. Green tea consumption and the risk of liver cancer in Japan: the Ohsaki Cohort study. Cancer Causes & Control 2009; 20(10): 1939 doi: 10.1007/s10552-009-9388-x
|
| 56 |
V. Schmitz, T. Sauerbruch. Früherkennung des hepatozellulären Karzinoms. Der Gastroenterologe 2007; 2(5): 356 doi: 10.1007/s11377-007-0104-7
|
| 57 |
Liming Lu, Jingchun Zeng, Zehuai Wen, Chunzhi Tang, Nenggui Xu. Transcatheter arterial chemoembolisation followed by three-dimensional conformal radiotherapy versus transcatheter arterial chemoembolisation alone for primary hepatocellular carcinoma in adults. Cochrane Database of Systematic Reviews 2019; 2019(2) doi: 10.1002/14651858.CD012244.pub2
|
| 58 |
Liming Lu, Jingchun Zeng, Zehuai Wen. Combination of three-dimensional conformal radiotherapy and transcatheter arterial chemoembolisation versus transcatheter arterial chemoembolisation for primary hepatocellular carcinoma. Cochrane Database of Systematic Reviews 2016; doi: 10.1002/14651858.CD012244
|
| 59 |
Zong-Hua Ao, Zheng-Hong Xu, Zhen-Ming Lu, Hong-Yu Xu, Xiao-Mei Zhang, Wen-Fang Dou. Niuchangchih (Antrodia camphorata) and its potential in treating liver diseases. Journal of Ethnopharmacology 2009; 121(2): 194 doi: 10.1016/j.jep.2008.10.039
|
| 60 |
David U. Lee, Elyse A. Adonizio, David J. Hastie, Reid Ponder, Ki Jung Lee, Daniel Jung, Gregory H. Fan, Raza Malik. The Trends in Health Care Utilization and Costs Associated With Primary Liver Cancer. Journal of Clinical Gastroenterology 2024; 58(7): 726 doi: 10.1097/MCG.0000000000001927
|
| 61 |
Gabriella Lengyel, János Fehér†. Combined interferon, ribavirin treatment and the occurrence of hepatocellular carcinoma. Orvosi Hetilap 2010; 151(29): 1177 doi: 10.1556/oh.2010.28925
|
| 62 |
Junting Huang, Li Xu, Yaoling Luo, Fengying He, Yaojun Zhang, Minshan Chen. The inflammation-based scores to predict prognosis of patients with hepatocellular carcinoma after hepatectomy. Medical Oncology 2014; 31(4) doi: 10.1007/s12032-014-0883-x
|